OrthoPediatrics Corp. (KIDS): Price and Financial Metrics
GET POWR RATINGS... FREE!
KIDS POWR Grades
- KIDS scores best on the Growth dimension, with a Growth rank ahead of 77.43% of US stocks.
- The strongest trend for KIDS is in Momentum, which has been heading down over the past 31 weeks.
- KIDS ranks lowest in Quality; there it ranks in the 10th percentile.
KIDS Stock Summary
- Orthopediatrics Corp's stock had its IPO on October 12, 2017, making it an older stock than merely 12.17% of US equities in our set.
- KIDS's price/sales ratio is 16.72; that's higher than the P/S ratio of 88.18% of US stocks.
- Over the past twelve months, KIDS has reported earnings growth of 196.06%, putting it ahead of 90.75% of US stocks in our set.
- Stocks that are quantitatively similar to KIDS, based on their financial statements, market capitalization, and price volatility, are DRQ, ASPU, XGN, VCYT, and JG.
- Visit KIDS's SEC page to see the company's official filings. To visit the company's web site, go to www.orthopediatrics.com.
KIDS Price Target
For more insight on analysts targets of KIDS, see our KIDS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $69.33 | Average Broker Recommendation | 1.43 (Moderate Buy) |
KIDS Stock Price Chart Interactive Chart >
KIDS Price/Volume Stats
| Current price | $66.44 | 52-week high | $66.64 |
| Prev. close | $64.57 | 52-week low | $38.01 |
| Day low | $64.36 | Volume | 198,400 |
| Day high | $66.64 | Avg. volume | 171,042 |
| 50-day MA | $57.86 | Dividend yield | N/A |
| 200-day MA | $49.51 | Market Cap | 1.31B |
OrthoPediatrics Corp. (KIDS) Company Bio
OrthoPediatrics Corp. designs, develops, and sells orthopedic implants for children. It offers trauma and deformity correction products, including cannulated screws; The Locking Cannulated Blade plate system that offers various treatment options for pediatric hip deformity, fixed knee flexion deformity, and trauma; The Locking Proximal Femur plate system for long bone fractures and osteotomies in children and adolescents; flexible nailing systems; The OP PediFrag System, a fragment set for pediatric orthopedic surgery; The PediLoc Extension Osteotomy plates; locking plated systems for the treatment of pediatric femur fractures and osteotomies; intramedullary nails; plate systems that provide physeal tethering techniques; and an engineered device for casting procedures. The company also offers spine and sports medicine systems, and clinical education. It serves medical professionals, patients, and families worldwide. OrthoPediatrics Corp. was founded in 2007 and is based in Warsaw, Indiana.
Latest KIDS News From Around the Web
Below are the latest news stories about Orthopediatrics Corp that investors may wish to consider to help them evaluate KIDS as an investment opportunity.
OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw SystemWARSAW, Ind., June 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the launch of its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis (“SCFE”) Cannulated Screw system. The company previously received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as expanded indications for its next generation Cannulated Screw System. The OrthoPediatrics 6.5mm/7.3 |
OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences ConferenceWARSAW, Ind., June 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Executive Chairman, are scheduled to participate in the 2021 JMP Securities Life Sciences Conference on Thursday, June 17, 2021. Event:2021 JMP Securities L |
OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive OfficerWARSAW, Ind., June 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the senior leadership transition, with David Bailey succeeding Mark Throdahl as Chief Executive Officer. Mark Throdahl will remain with the Company as Executive Chairman. “Over the last 10 years, it has been a privilege to work with our remarkable team leading the effort to improv |
OrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis SystemWARSAW, Ind., May 28, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of its RESPONSE™ Neuromuscular Scoliosis System. This will be the 36th surgical system the Company has launched. The system received FDA 510(k) clearance in 2020, and the Company has been preparing for a full-scale domestic launch this summer. RESPONSE Neuromuscular (“RESPONSE NM”) represents the latest addition to the RESPONSE Scoliosis platform, which is designed to treat pediatric patients. This new system is dedicated for the treatment of neuromuscular scoliosis and was developed in conjunction with pediatric orthopedic surgeons to address the distinct challenges in treating a uniq... |
OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA MeetingWARSAW, Ind., May 17, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, has continued the Company’s support for the 2021 Pediatric Orthopaedic Society of North America (POSNA) annual meeting, held last week in Dallas, Texas. Despite the lingering effects of the COVID-19 pandemic and travel restrictions, more than 400 attendees from across the United States participated in this year’s event. OrthoPediatrics retains its designation as a Double Diamond Sponsor, providing ongoing support of a sub-specialty day symposia and awarding scholarships for residents and fellows to attend the meeting. In addition to its Trauma and Deformity Correction portfolio, the Company highlighted its... |
KIDS Price Returns
| 1-mo | 23.22% |
| 3-mo | 41.39% |
| 6-mo | N/A |
| 1-year | 48.47% |
| 3-year | 148.37% |
| 5-year | N/A |
| YTD | 61.07% |
| 2020 | -12.22% |
| 2019 | 34.72% |
| 2018 | 81.76% |
| 2017 | N/A |
| 2016 | N/A |
Continue Researching KIDS
Here are a few links from around the web to help you further your research on Orthopediatrics Corp's stock as an investment opportunity:Orthopediatrics Corp (KIDS) Stock Price | Nasdaq
Orthopediatrics Corp (KIDS) Stock Quote, History and News - Yahoo Finance
Orthopediatrics Corp (KIDS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...